Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haemodialysis.

N P Mallick1, R Gokal

  • 1Department of Renal Medicine, Manchester Royal Infirmary, UK.

Lancet (London, England)
|March 12, 1999
PubMed
Summary
This summary is machine-generated.

Haemodialysis has significantly improved survival and quality of life for end-stage renal failure patients. Advances allow treatment for older, sicker individuals, but managing comorbidities and cost-effectiveness remains key.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcome of pregnancy following renal transplantation.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2004
Same author

Bacillus circulans peritonitis in a patient treated with CAPD.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2004
Same author

End-stage renal disease in Indo-Asians in the North-West of England.

QJM : monthly journal of the Association of Physicians·2003
Same author

Treatment of infections in peritoneal dialysis.

Contributions to nephrology·2003
Same author

Peritoneal dialysis as the first-choice treatment.

Contributions to nephrology·2003
Same author

Side-effects of antituberculosis drug treatment in patients with chronic renal failure.

The European respiratory journal·2002
Same journal

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Lancet (London, England)·2026
Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
See all related articles

Area of Science:

  • Nephrology
  • Medical Technology
  • Patient Care

Background:

  • Renal replacement therapy (RRT) is crucial for end-stage renal failure.
  • Haemodialysis has evolved into a cornerstone treatment.
  • Technological progress enables RRT for complex patient groups.

Purpose of the Study:

  • To chart the historical development of haemodialysis.
  • To examine the impact of technological advances on RRT.
  • To discuss the balance between treatment standards, cost-effectiveness, and patient quality of life.

Main Methods:

  • Historical review of haemodialysis development.
  • Analysis of RRT application in diverse patient populations.
  • Discussion of quality of life as a justification for RRT.

Related Experiment Videos

Main Results:

  • Haemodialysis significantly extends survival for end-stage renal failure patients.
  • Improved technology allows treatment for older and comorbid patients.
  • Quality of life is a critical factor in evaluating RRT efficacy.

Conclusions:

  • Haemodialysis is a vital therapy improving patient survival and quality of life.
  • Adapting RRT for complex patients requires balancing advanced care with cost-effectiveness.
  • Ensuring a satisfactory quality of life justifies the commitment to haemodialysis.